Looking at the cash flow statement, we can see that the 42% increase in SBC slightly impacted earnings, reporting mid-teen ...
Genmab shifts to innovation-led growth with 21% revenue, 52% operating profit, $3.4B cash, Epkinly, Rina-S, and Anthropic AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback